BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO Potential Makes A Buy

This is my third BioMarin (NASDAQ: BMRN ) article following 07/2024's "BioMarin Pharmaceutical: Steady Performer Scheduling Its Big Reveal" (" Big Reveal "). In the interim BioMarin has dropped >26%. Whenever a company loses that much that fast a fundamental question arises; is itWriting under the pseudonym "out of ignorance", I very much regard investing as a learning process. Investing failures are tuition paid. Investing successes enter the trove of lessons learned. In my Seeking Alpha articles I share m ...